Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bryan C Fuchs

Showing results (81-90 of 99) with videos related to

Pageof 10
Sort By:
Radiology|November 21, 2017
CM-101: Type I Collagen-targeted MR Imaging Probe for Detection of Liver FibrosisChristian T Farrar, Eric M Gale, Richard Kennan, et al.
Hepatology (Baltimore, Md.)|March 15, 2018
Tyrosine kinase SYK is a potential therapeutic target for liver fibrosisChen Qu, Dandan Zheng, Sai Li, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|November 22, 2017
Cell type-specific pharmacological kinase inhibition for cancer chemopreventionManjeet Deshmukh, Shigeki Nakagawa, Takaaki Higashi, et al.
Hepatology (Baltimore, Md.)|March 29, 2014
Epidermal growth factor receptor inhibition attenuates liver fibrosis and development of hepatocellular carcinomaBryan C Fuchs, Yujin Hoshida, Tsutomu Fujii, et al.
JCI Insight|June 2, 2017
Molecular imaging of oxidized collagen quantifies pulmonary and hepatic fibrogenesisHoward H Chen, Philip A Waghorn, Lan Wei, et al.
Clinical Transplantation|February 9, 2016
Impact of EGF, IL28B, and PNPLA3 polymorphisms on the outcome of allograft hepatitis C: a multicenter studyJessica L Mueller, Lindsay Y King, Kara B Johnson, et al.
Cellular and Molecular Gastroenterology and Hepatology|January 30, 2022
Peroxidasin Deficiency Re-programs Macrophages Toward Pro-fibrolysis Function and Promotes Collagen Resolution in LiverMozhdeh Sojoodi, Derek J Erstad, Stephen C Barrett, et al.
Hepatology Communications|July 21, 2018
Molecular magnetic resonance imaging accurately measures the antifibrotic effect of EDP-305, a novel farnesoid X receptor agonistDerek J Erstad, Christian T Farrar, Sarani Ghoshal, et al.
Med (New York, N.Y.)|July 28, 2021
A blood-based prognostic liver secretome signature and long-term hepatocellular carcinoma risk in advanced liver fibrosisNaoto Fujiwara, Masahiro Kobayashi, Austin J Fobar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 3, 2020
Fibrotic Response to Neoadjuvant Therapy Predicts Survival in Pancreatic Cancer and Is Measurable with Collagen-Targeted Molecular MRIDerek J Erstad, Mozhdeh Sojoodi, Martin S Taylor, et al.
Pageof 10

Showing results (81-90 of 99) with videos related to

Sort By:
Pageof 10
Radiology|November 21, 2017
CM-101: Type I Collagen-targeted MR Imaging Probe for Detection of Liver FibrosisChristian T Farrar, Eric M Gale, Richard Kennan, et al.
Hepatology (Baltimore, Md.)|March 15, 2018
Tyrosine kinase SYK is a potential therapeutic target for liver fibrosisChen Qu, Dandan Zheng, Sai Li, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|November 22, 2017
Cell type-specific pharmacological kinase inhibition for cancer chemopreventionManjeet Deshmukh, Shigeki Nakagawa, Takaaki Higashi, et al.
Hepatology (Baltimore, Md.)|March 29, 2014
Epidermal growth factor receptor inhibition attenuates liver fibrosis and development of hepatocellular carcinomaBryan C Fuchs, Yujin Hoshida, Tsutomu Fujii, et al.
JCI Insight|June 2, 2017
Molecular imaging of oxidized collagen quantifies pulmonary and hepatic fibrogenesisHoward H Chen, Philip A Waghorn, Lan Wei, et al.
Clinical Transplantation|February 9, 2016
Impact of EGF, IL28B, and PNPLA3 polymorphisms on the outcome of allograft hepatitis C: a multicenter studyJessica L Mueller, Lindsay Y King, Kara B Johnson, et al.
Cellular and Molecular Gastroenterology and Hepatology|January 30, 2022
Peroxidasin Deficiency Re-programs Macrophages Toward Pro-fibrolysis Function and Promotes Collagen Resolution in LiverMozhdeh Sojoodi, Derek J Erstad, Stephen C Barrett, et al.
Hepatology Communications|July 21, 2018
Molecular magnetic resonance imaging accurately measures the antifibrotic effect of EDP-305, a novel farnesoid X receptor agonistDerek J Erstad, Christian T Farrar, Sarani Ghoshal, et al.
Med (New York, N.Y.)|July 28, 2021
A blood-based prognostic liver secretome signature and long-term hepatocellular carcinoma risk in advanced liver fibrosisNaoto Fujiwara, Masahiro Kobayashi, Austin J Fobar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 3, 2020
Fibrotic Response to Neoadjuvant Therapy Predicts Survival in Pancreatic Cancer and Is Measurable with Collagen-Targeted Molecular MRIDerek J Erstad, Mozhdeh Sojoodi, Martin S Taylor, et al.
Pageof 10